The presence of KRAS mutation in pancreatic juice has been frequently observed in patients with pancreatic cancer (80%) and also in patients with chronic pancreatitis (CP) before the development of PC [13,14,15,16], suggesting that it may be useful in identifying CP patients who are at a higher risk of developing cancer. The gene discussed is KRAS; the disease is cancer.